Who owns PTX - PERNIX THERAPEUTICS HLDGS IN - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

PERNIX THERAPEUTICS HLDGS IN - COM (PTX) Institutional Ownership

Q: What is CUSIP 71426V108?

CUSIP 71426V108 is the security identifier used in SEC filing datasets for PTX - PERNIX THERAPEUTICS HLDGS IN - COM.

CUSIP: 71426V108

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2016

Type / Class: Equity / COM
Symbol: PTX

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 71426V108:

Q4 2016 (0 holders) Q3 2016 (40 holders) Q2 2016 (48 holders) Q1 2016 (78 holders) Q4 2015 (96 holders) Q3 2015 (102 holders) Q2 2015 (110 holders) Q1 2015 (112 holders) Q4 2014 (93 holders) Q3 2014 (76 holders)

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2016 Q4	0	$0	-$8,020,000	$0			0
2016 Q3	12,908,295	$8,022,000	+$840,727	$46,000		$0.62	40
2016 Q2	12,325,290	$5,521,000	-$25,299,924	$34,000		$0.45	48
2016 Q1	39,830,013	$41,817,000	-$7,278,435	$16,000		$1.05	78
2015 Q4	43,461,693	$128,198,181	-$7,235,655	$216,000		$2.95	96
2015 Q3	42,891,261	$135,525,128	+$4,996,581	$81,000		$3.16	102
2015 Q2	33,248,729	$196,814,740	-$37,565,600	$203,000	$0	$5.92	110
2015 Q1	34,244,291	$365,960,746	+$35,572,970	$187,000	$566,125	$10.69	112
2014 Q4	31,077,479	$291,780,527	+$45,983,284	$1,725,000	$550,000	$9.39	93
2014 Q3	24,250,371	$186,234,467	+$23,234,390	$1,418,000	$703,000	$7.68	76
2014 Q2	19,595,404	$175,898,227	+$76,244,057	$3,077,000	$2,724,000	$8.98	86
2014 Q1	16,907,801	$86,684,966	+$38,526,112		$313,000	$5.35	58